Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Mol Ther. 2013 Jul;21(7):1369-77. doi: 10.1038/mt.2013.58. Epub 2013 Apr 9.
Engineering CD8⁺ T cells to deliver interleukin 12 (IL-12) to the tumor site can lead to striking improvements in the ability of adoptively transferred T cells to induce the regression of established murine cancers. We have recently shown that IL-12 triggers an acute inflammatory environment that reverses dysfunctional antigen presentation by myeloid-derived cells within tumors and leads to an increase in the infiltration of adoptively transferred antigen-specific CD8⁺ T cells. Here, we find that local delivery of IL-12 increased the expression of Fas within tumor-infiltrating macrophages, dendritic cells, and myeloid-derived suppressor cells (MDSC), and that these changes were abrogated in mice deficient in IL-12-receptor signaling. Importantly, upregulation of Fas in host mice played a critical role in the proliferation and antitumor activity of adoptively transferred IL-12-modified CD8⁺ T cells. We also observed higher percentages of myeloid-derived cell populations within tumors in Fas-deficient mice, indicating that tumor stromal destruction was dependent on the Fas death receptor. Taken together, these results describe the likely requirement for costimulatory reverse signaling through Fasl on T cells that successfully infiltrate tumors, a mechanism triggered by the induction of Fas expression on myeloid-derived cells by IL-12 and the subsequent collapse of the tumor stroma.
将工程化的 CD8⁺ T 细胞递送至肿瘤部位以递送白细胞介素 12 (IL-12) ,可以显著提高过继转移的 T 细胞诱导已建立的小鼠癌症消退的能力。我们最近表明,IL-12 引发急性炎症环境,逆转肿瘤内髓样来源细胞的功能失调的抗原呈递,并导致过继转移的抗原特异性 CD8⁺ T 细胞的浸润增加。在这里,我们发现局部递送 IL-12 增加了肿瘤浸润巨噬细胞、树突状细胞和髓样来源抑制细胞 (MDSC) 中 Fas 的表达,并且这些变化在缺乏 IL-12 受体信号的小鼠中被消除。重要的是,宿主小鼠中 Fas 的上调在过继转移的 IL-12 修饰的 CD8⁺ T 细胞的增殖和抗肿瘤活性中发挥了关键作用。我们还观察到 Fas 缺陷型小鼠肿瘤内髓样细胞群体的百分比更高,表明肿瘤基质的破坏依赖于 Fas 死亡受体。总之,这些结果描述了通过 Fasl 在成功浸润肿瘤的 T 细胞上进行共刺激反向信号的可能要求,这是由 IL-12 诱导的髓样来源细胞上 Fas 的表达以及随后的肿瘤基质崩溃触发的机制。